(Q36854773)

English

Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans

scientific article published on July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Salmonella enterica

0 references

1 reference

based on heuristic

inferred from title

author name string

Marcelo B Sztein

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

0 references

publication date

1 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

45 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

S15-9

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Host-Salmonella interaction: human trials

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Typhoid fever: pathogenesis and immunologic control. 2.

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Second attacks of typhoid fever

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Typhoid fever: pathogenesis and immunologic control

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine

1 reference

https://api.crossref.org/works/10.1086%2F518140

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36854773&oldid=2087624681"